Smooth muscle a-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex

Circulation Research

Volumn 86, Issue 2, 2000, Pages 221-232

  Mack, Christopher P ^a   Thompson, Maria M ^a   Lawrenz Smith, Susan ^a   Owens, Gary K ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

CArG element; Serum response factor; Smooth muscle a actin

Indexed keywords

ALPHA ACTIN; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR; ACTIN; DNA BINDING PROTEIN; ELK1 PROTEIN, RAT; ERYTHROID SPECIFIC DNA BINDING FACTOR; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR ELK 4;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; GENE SEQUENCE; METHYLATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER; ANIMAL; AORTA; CATTLE; CELL CULTURE; CHEMISTRY; CONFORMATION; CYTOLOGY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MUTAGENESIS; PHYSIOLOGY; PROTEIN BINDING; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; AORTA; CATTLE; CELLS, CULTURED; DNA FOOTPRINTING; DNA METHYLATION; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; ETS-DOMAIN PROTEIN ELK-1; ETS-DOMAIN PROTEIN ELK-4; GENE EXPRESSION REGULATION; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS; NUCLEAR PROTEINS; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RATS; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033622053     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.2.221     Document Type: Article

References (11)

1. Ross R. The pathogenesis of atherosclerosis. N Engl J Med. 1976; 295(pt 1):369-377.
2. Schwartz SM, Ross R. Cellular proliferation in atherosclerosis and hypertension. Prog Cardiovasc Dis. 1984:26:355-372.
3. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995:75:487-517.
4. Chamley-Campbell JH, Campbell GR. What controls smooth muscle phenotype? Atherosclerosis. 1981;40:347-357.
5. Glukhova MA, Kabakov AE, Frid MG, Ornatski OI, Belkin AM, Muhkin AM, Orekov AN, Koteliansky VE, Smirnov VN. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Nat Acad Sci U S A. 1988;85:9542-9546.
6. Liau G, Winkles JA, Cannnon MS, Kuo L, Chililan WM. Dietary-induced atherosclerotic lesions have increased levels of acidic FGF mRNA and altered cytoskeletal and extracellular matrix mRNA expression. J Vasc Res. 1993:30:327-332.
7. Kocher O, Gabbiani F, Gabbiani G, Reidy MA, Cokay MS, Peters H, Huttner I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening: biochemical and morphologic-studies. Lab Invest. 1991;65:459-470.
8. Kocher O, Gabbiani G. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol. 1986;17:875-880.
9. Duband JL, Gimona M, Scatena S, Sartore S, Small JV. Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation. 1993; 55:1-11.
10. Fatigati V, Murphy RA. Actin and tropomyosin variants in smooth muscle: dependence on tissue type. J Biol Chem. 1984;259:14383-14388.
11. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest. 1990:63:21-29.